The Institute of Health Economics and Applied Pharmaceutical Innovation collaborate to support early economic analysis in drug research and development
The Institute of Health Economics is pleased to announce a new collaboration with Applied Pharmaceutical Innovation.
The Institute of Health Economics (IHE) and Applied Pharmaceutical Innovation (API) are creating value through collaboration. The IHE and API have signed a Memorandum of Understanding (MOU) in the field of economic analysis and health technology assessment to support each other’s aspiration in the development of a broader, stronger, and more vibrant innovation ecosystem.
“Successful drug development requires the establishment of a translational team who can move discoveries forward in a regulatory compliant environment,” said Andrew MacIsaac, Chief Executive Officer of API. “Through engagements such as this, API is able to provide a framework that builds these translational teams and unlocks the potential of innovative science within post-secondary institutions. We look forward to plugging IHE’s team into our work to develop solid market cases for SMEs.”
As part of the MOU, API and the IHE will explore opportunities to collaborate on an ongoing basis, including promoting and supporting the missions and goals of each respective organization, as well as leveraging each other’s combined expertise.
“The best way to bring new innovation from ‘bench to bedside’ is through the power of collaboration,” said Dr. Christopher McCabe, Executive Director and CEO of the IHE. “Engagements such as this one allows us to bring together broadly networked expertise to address significant and often complex research and policy challenges – bridging gaps and bringing the health sector closer together.”
API is a not-for-profit that works in collaboration with the University of Alberta’s Faculty of Pharmacy and Pharmaceutical Sciences as well as research and post-secondary institutions across Canada. We draw on an interdisciplinary network of over 30 pharmaceutical scientists, clinicians, regulatory, patent, and market experts in a variety of fields and disease areas to bring life-saving research to the real world. For more information, visit appliedpharma.ca.
The IHE is an independent, not-for-profit organization that performs excellence in health economics research and health technology assessment. Our core objectives include: supporting decision-making in health policy and practice with evidence from research in health economics and health technology assessment; assessing the medical, economic, social, and ethical implications and potential of both established and new health practices, procedures, and technologies; and facilitating discussions and partnerships among government, academia, industry, and healthcare providers to address important issues in health care. Visit us at www.ihe.ca to learn more.
Director of Communications, Institute of Health Economics
Direct: (780) 401-1768 | Cell: (780) 966-4879
Business Officer, Applied Pharmaceutical Innovation
Phone: (780) 700-3496